期刊文献+

TGF-β介导间充质干细胞对肝癌干细胞的调控 被引量:3

TGF-β mediates the regulation of liver cancer stem cells by mesenchymal stem cells
下载PDF
导出
摘要 目的观察间充质干细胞(mesenchymal stem cells,MSCs)对SMMC-7721肝癌细胞中肿瘤干细胞的调控作用及其相关机制。方法将MSCs与肝癌细胞混合注入裸鼠体内,观察种植瘤生成情况。用MSCs条件培养上清体外培养肝癌细胞,流式细胞仪检测其CD133+细胞比例改变情况。ELISA检测MSCs条件培养上清中TGF-β的浓度。TGF-β处理肝癌细胞,流式细胞仪检测其CD133+细胞比例改变情况。结果裸鼠种植瘤实验显示MSCs在体内可以促进肝癌生成。体外用MSCs条件培养上清培养SMMC-7721肝癌细胞株可上调其中CD133+细胞比例,呈时间依赖性。MSCs分泌TGF-β至培养上清,TGF-β处理肝癌细胞可上调其中CD133+细胞的比例,并亦呈时间依赖性。结论 MSCs对肝癌干细胞具有调控作用,TGF-β参与介导MSCs的这一作用。 Objective To investigate the effect of mesenchymal stem cells (MSCs) on the regulation of cancer stem cells in liver cancer cell line SMMC-7721 and the underlying mechanism. Methods The mixture of MSCs and SMMC-7721 liver cancer cells were injected subcutaneously into nude mice. CD133 + cell content was detected by flow cytometry after cultured with MSCs conditioned medium or treatment with TGF-β. ELISA was employed to examine the concentration of TGF-β in MSCs conditioned medium. Results MSCs promoted xenograft tumor growth in vivo. CD133 + cancer cell content was increased when SMMC-7721 cells were cultured with MSCs conditioned medium or treated with TGF-β in a time-dependent manner. MSCs secreted TGF-β to the medium. Conclusions MSCs can up-regulate cancer stem cell in liver cancer cell line SMMC-7721 ,which is mediated by TGF-β.
作者 孙杰 时纪元
出处 《实用肿瘤杂志》 CAS 2013年第2期186-189,共4页 Journal of Practical Oncology
关键词 肝肿瘤/药物作用 间质干细胞 抗原 CD/分析 转化生长因子β1/药理学 肿瘤干细胞 肿瘤细胞 培养的/药物作用 liver neoplasms/drug effects mesenchymal stem cells antigens, CD/analysis transforming growth factor betal/ pharmacology neoplastic stem cells tumor cells, cultured/drug effects
  • 相关文献

参考文献10

  • 1Tong CM, Ma S, Guan XY. Biology of hepatic cancer stem cells [ J ]. J Gastroenterol Hepatol, 2011,26 ( 8 ) : 1229 - 1237.
  • 2Klopp AH,Lacerda L, Gupta A, et al. Mesenchymal stem cells promote mammosphere formation and decrease E- cadherin in normal and malignant breast cells [ J ]. PLoS One,2010,5 (8) :e12180.
  • 3Tsai KS,Yang SH, Lei YP, et al. Mesenchymal stem cells promote formation of colorectal tumors in mice [ J ]. Gastroenterology,2011,141 (3) : 1046 - 1056.
  • 4Liu S, Ginestier C, Ou SJ, et al. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks [J]. Cancer Res,2011,71 (2):614 -624.
  • 5Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease [J]. Nat Rev Immunol, 2008,8 (9) :726 -736.
  • 6Hsu HS, Lin JH, Hsu TW, et al. Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/ JAK2/STAT3 pathway [J]. Lung Cancer,2011,75 (2): 167 - 177.
  • 7Liu CH, Hwang SM. Cytokine interactions in mesenchymal stem cells from cord blood [ J ]. Cytokine, 2005,32 ( 6 ) : 270 - 279.
  • 8Singh A, Settleman J. EMT, cancer stem cells and drug resistance:an emerging axis of evil in the war on cancer [ J ]. Oncogene, 2010,29 ( 34 ) :4741 - 4751.
  • 9Shipitsin M, Campbell LL, Argani P, et al. Molecular definition of breast tumor heterogeneity [ J]. Cancer Cell, 2007,11 (3) :259 -273.
  • 10Wang Y, Yu Y, Tsuyada A, et al. Transforming growth factor-beta regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM [ J ]. Oneogene,2011,30 ( 12 ): 1470 - 1480.

同被引文献35

  • 1Da-Ming Zhang,Jian-Jun Li,Peng Yan,Jian-Ting Hu.Establishment and identification of induced pluripotent stem cells in liver cancer patients[J].Asian Pacific Journal of Tropical Medicine,2014,7(4):253-256. 被引量:1
  • 2Wei-Hui Liu,Li-Na Ren,Tao Chen,Li-Ye Liu,Li-Jun Tang.Stages based molecular mechanisms for generating cholangiocytes from liver stem/progenitor cells[J].World Journal of Gastroenterology,2013,19(41):7032-7041. 被引量:3
  • 3乔玲,赵铁军,山长亮,叶丽虹,张晓东.人间充质干细胞抑制肝癌细胞增殖的作用及其基因表达谱分析[J].中国生物化学与分子生物学报,2007,23(12):1037-1044. 被引量:8
  • 4Lavery K,Swain P,Falb D,et al. BMP-2/4 and BMP-6/7differentially utilize cell surface receptors to induceosteoblastic differentiation of human bone marrow-derivedmesenchymal stem cells [ J ] . J Biol Chem,2008,283(30) :20948 -20958.
  • 5Mylotte LA, Duffy AM, Murphy M, et al. Metabolicflexibility permits mesenchymal stem cell survival in anischemic environment [ J ]. Stem Cells,2008,26 ( 5 ):1325 -1336.
  • 6Wan XC,Zhang J,Luo HY,et al. A TNF family memberLIGHT transduces costimulatory signals into human Tcells [J]. J Immunol,2002,169( 12) :6813 -6821.
  • 7Shaikh RB , Santee S, Granger SW, et al. Constitutiveexpression of LIGHT on T cells leads to lymphocyteactivation,inflammation, and tissue destruction [ J ]. JImmunol,2001,167 (11) : 6330 - 6337.
  • 8Jarvinen L, Badri L, Wettlaufer S, et al. Lung residentmesenchymal stem cells isolated from human lungallografts inhibit T cell proliferation via a soluble mediator[J]. J Immunol,2008,181 (6) -.4389 -4396.
  • 9Beckermann BM, Kallifatidis G, Groth A, et al. VEGFexpression by mesenchymal stem cells contributes toangiogenesis in pancreatic carcinoma [ J ] . Br J Cancer,2008,99(4) :622 -631.
  • 10Liotta F,Angeli R, Cosmi L, et al. Toll-like receptors 3and 4 are expressed by human bone marrow-derivedmesenchymal stem cells and can inhibit their T-cellmodulatory activity by impairing Notch signaling [ J ].Stem Cells,2008,26(l) :279 -289.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部